The Management of Obesity and Related Disorders

By Peter G. Kopelman | Go to book overview

such treatment to such patients who are able to benefit.


References
1
Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A, The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction, Int J Obesity (1999) 23:1016-24.
2
Drent ML, van derVeen EA, Lipase inhibition-a novel concept in the treatment of obesity, Int J Obesity (1993) 17:241-4.
3
Holman RR, Cull CA, Turner RC, A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (UK Prospective Diabetes Study 44), Diabetes Care (1999) 22:960-4.
4
Wilding JPH, Widdowson PS, Williams G, Neurobiology, Br Med Bull (1997) 53:286-306.
5
Finer N, Present and future pharmacological approaches, Br Med Bull (1997) 53:409-32.
6
Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A, Thermogenic effects of sibutramine in humans, Am J Clin Nutr (1998) 68:1180-6.
7
Royal College of Physicians. Clinical management of overweight and obese patients, with particular reference to the use of drugs, 1998.
8
Obesity in Scotland: Integrating Prevention with Weight Management, 8, 1996. Edinburgh, SIGN.
9
Munro JF, MacCuish AC, Wilson EM, Duncan LJP, Comparison of continuous and intermittent anorectic therapy in obesity, Br Med J (1968) 1:352-4.
10
Wilding JPH, Gilbey SG, Jones PM, Mannan MM, Ghatei MA, Bloom SR, Dexfenfluramine treatment and hypothalamic neuropeptides in diet-induced obesity in rats, Peptides (1992) 13:557-63.
11
Connolly HM, Crary JL, McGoon MD et al, Valvular heart disease associated with fenfluramine-phentermine, N Engl J Med (1997) 337:581-8.
12
Abenhaim I, Moride Y, Brenot F, Appetite suppressant drugs and the risk of primary pulmonary hypertension, N Engl J Med (1996) 335:609-16.
13
Connolly VM, Gallagher A, Kesson CM, A study of fluoxetine in obese elderly patients withtype 2 diabetes, Diabet Med (1995) 12:416-8.
14
Goldstein DJ, Rampey AH, Enas GG, Potvin JH, Fludzinski LLA, Levine LR, Fluoxetine-a randomized clinical-trial in the treatment of obesity, Int J Obesity (1994) 18:129-35.
15
Hartmann D, Hussain Y, Guzelhan C, Odink J, Effect on dietary-fat absorption of orlistat, administered at different times relative to meal intake, Br J Clin Pharmacol (1993) 36:266-70.
16
Sjostrom L, Rissanen A, Andersen T et al, Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients, Lancet (1998) 352:167-72.
17
Sjostrom L, Rissanen A, Andersen T et al, Weight loss and prevention of weight regain inobese patients: a 2-year, European, randomised trial of orlistat, Lancet (1998) 352:167-72.
18
Davidson MH, Hauptman J, DiGirolamo M et al, Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat - a randomized controlled trial, JAMA (1999) 281:235-42.
19
Rissanen A, Sjostrom L, Rossner S, Early weight

-219-

Notes for this page

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Project items

Items saved from this book

This book has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this book

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this page

Cited page

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited page

Bookmark this page
The Management of Obesity and Related Disorders
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this book

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen
/ 258

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.